The Inventor: Out for Blood in Silicon Valley

Xi Zhang
Xi Zhang
Published in
2 min readJan 13, 2020

Silicon Valley’s biggest flop. Stunning downfall of a $9 billion dollars silicon valley biotech unicorn created by a fairy tale 19-year-old young woman who dropped out of Harvard who wooed the entire silicon valley, investors, customers, and the most powerful politicians.

Elizabeth Holmes was a dream for many. She is young. She’s bright. She’s ambitious. Most importantly, she sees a vision that will revolutionize the medical world. With a drop of blood, her patented technology system Edison can pre-diagnose hundreds of diseases at a low cost. It all turns out to be a mega lie to gain traction, power, and investment. Many young girl’s role model is, in reality, a con artist who justifies her lies with preceding silicon valley success stories, Microsoft Bill Gates, Apple Steve Jobs’ unusual path to success. But Elizabeth failed to see the biggest difference between her venture and those of Steve and Bill — she puts people’s lives on the line literally. The highly inaccurate results created by Edison has given false diagnose to thousands of beta customers who have naively put their faith in it.

Besides amazement, disappointment, and anger, I still have hope. This might still be possible. Elizabeth is not the one to bring this dream to life. I’m hoping another little girl or little boy somewhere in the world will conquer this peak and be the true hero of humanity.

--

--